Pharmaceutical Contract Development and Manufacturing Market - Trends Forecast Till 2028

Pharmaceutical Contract Development and Manufacturing Market, By Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids, End User (Big Pharma, Small Pharma, Generic Pharma, CRO) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa and South America)

Published Date: April, 2021

Base Year Estimate: 2020

Report ID: D-PH-PCDMM-147

Format:  

Number of Pages: 349

Domain: Pharmaceutical

Pharmaceutical Contract Development and Manufacturing Market – Trends Forecast Till 2028

Global Pharmaceutical Contract Development and Manufacturing market is anticipated to reach USD 103.8 billion in 2021 growing at a CAGR of 7.9% during the forecasting period, 2021-2028.

Contract manufacturing in pharmaceutical industry are term used companies that provide the services of drug manufacturing and others and work on contact basis. They don’t brand their name that is they work under the label/branding of the other company. They are unable to buy the raw material (due to its heavy price) used and thus on contract basis they are able to get the raw material and are able to process it to make chemicals. The brands are thus also able to outsource their work.

With an increased research in the pharmaceutical sector along with patent expiry and an increased demand for generic medicine are some of the factors that have supported long-term expansion for the Pharmaceutical Contract Development and Manufacturing industry.

Pharmaceutical Contract Development and Manufacturing Market Analysis

Global Pharmaceutical Contract Development and Manufacturing market is segmented into Pharmaceutical, Biologics, Active Pharma ingredients, tablet, Parenteral, Oral Liquid, Semi-Solids, end-user and geography.

The end-User segment is segmented into Big Pharma, Small Pharma, Generic Pharma, CRO

Geographically, the global Pharmaceutical Contract Development and Manufacturing market is sub-segmented into North America, Europe, Asia-Pacific, Middle East and Africa and South America and insights are provided for each region and major countries within the regions

Key players in the global Pharmaceutical Contract Development and Manufacturing market are Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Lonza Group Ltd. (Switzerland), Recipharm AB (Sweden), Vetter Pharma International GmbH (Germany), FAMAR Health Care Services (France), AbbVie Inc. (US), Aenova Group (Germany), Almac Group (UK), Siegfried Holding AG (Switzerland), Evonik Industries AG (Germany), WuXi AppTec (China), Samsung BioLogics (South Korea), Boehringer Ingelheim International GmbH (Germany), Cambrex Corporation (US), CordenPharma International (Germany), Albany Molecular Research Inc. (AMRI) (US), FUJIFILM Corporation (Japan), Piramal Pharma Solutions (India), Baxter International Inc. (US), Eurofins Scientific (Germany), BioVectra (Canada), Jubilant Life Science (India), NextPharma (UK), and Delpharm (France) among others.

Available Customizations

In addition to the market data for Pharmaceutical Contract Development and Manufacturing market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentations, conferences like Jefferies conference—to identify and collect information useful for this study of the Pharmaceutical Contract Development and Manufacturing market. The purpose of secondary research was to identify and collection of extensive, technical, market-oriented, and commercial studies of the global Pharmaceutical Contract Development and Manufacturing market. Through secondary research,  the market is classified and segmented as per industry trend, development, regional market, products, and technological development.

Primary Research

The primary sources mainly included several industry experts from the core and related industries and suppliers, manufacturers, distributors, alliances, and organizations related to all segments of this industry’s supply chain. In-depth interviews were conducted with various primary respondents—including key industry participants, subject matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts—to obtain and verify critical qualitative and quantitative information as well as to assess future prospects. The following figure depicts the market research methodology used in drafting this report on the Pharmaceutical Contract Development and Manufacturing market.

Primary Respondent breakdown is given below:

Pharmaceutical Contract Development and Manufacturing Market Primary Respondents

 

Market Sizing

Top-down and bottom approaches were used to derive the market estimate and validate the total revenue of the Pharmaceutical Contract Development and Manufacturing market. This approach has also been used to derive the market for segmentation and sub-segmentation.

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact primary respondents in order to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions on the basis of sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends and factors
  • Gain authentic and granular data access for Pharmaceutical Contract Development and Manufacturing market so as to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 103.8 billion

Growth Rate

CAGR of 7.9% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product, Application, End-User and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Thermo Fisher Scientific Inc. (US), Catalent, Inc. (US), Lonza Group Ltd. (Switzerland), Recipharm AB (Sweden), Vetter Pharma International GmbH (Germany), FAMAR Health Care Services (France), AbbVie Inc. (US), Aenova Group (Germany), Almac Group (UK), Siegfried Holding AG (Switzerland), Evonik Industries AG (Germany), WuXi AppTec (China), Samsung BioLogics (South Korea), Boehringer Ingelheim International GmbH (Germany), Cambrex Corporation (US), CordenPharma International (Germany), Albany Molecular Research Inc. (AMRI) (US), FUJIFILM Corporation (Japan), Piramal Pharma Solutions (India), Baxter International Inc. (US), Eurofins Scientific (Germany), BioVectra (Canada), Jubilant Life Science (India), NextPharma (UK), and Delpharm (France)

Available Customization

In addition to the market data for Pharmaceutical Contract Development and Manufacturing market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.